Teva Pharmaceutical Industries (LTS:0LER) Other Long-Term Liabilities : $4,344 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Teva Pharmaceutical Industries Other Long-Term Liabilities?

Teva Pharmaceutical Industries's other long-term liabilities for the quarter that ended in Sep. 2024 was $4,344 Mil.

Teva Pharmaceutical Industries's quarterly other long-term liabilities increased from Mar. 2024 ($3,991 Mil) to Jun. 2024 ($4,357 Mil) but then declined from Jun. 2024 ($4,357 Mil) to Sep. 2024 ($4,344 Mil).

Teva Pharmaceutical Industries's annual other long-term liabilities increased from Dec. 2021 ($2,578 Mil) to Dec. 2022 ($3,944 Mil) and increased from Dec. 2022 ($3,944 Mil) to Dec. 2023 ($4,019 Mil).

Teva Pharmaceutical Industries Other Long-Term Liabilities Historical Data

The historical data trend for Teva Pharmaceutical Industries's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Other Long-Term Liabilities Chart

Teva Pharmaceutical Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Teva Pharmaceutical Industries Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Teva Pharmaceutical Industries Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Teva Pharmaceutical Industries Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Teva Pharmaceutical Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (LTS:0LER) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

TEVJF:USA TEVA:USA TEVA:Mexico TEVA:Israel TEV:Germany TEV:Germany TEV:Germany T1EV34:Brazil TEV:Bulgaria TEVA:Austria

Address

124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020

Website

https://www.tevapharm.com

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Headlines

No Headlines